These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 19237251)

  • 1. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?
    Van Houdenhove B; Van Den Eede F; Luyten P
    Med Hypotheses; 2009 Jun; 72(6):701-5. PubMed ID: 19237251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic fatigue syndrome: a psychoneuroimmunological perspective].
    van Houdenhove B; Heijnen CJ
    Tijdschr Psychiatr; 2009; 51(8):603-10. PubMed ID: 19658073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroaetiology of chronic fatigue syndrome: an overview.
    Sanders P; Korf J
    World J Biol Psychiatry; 2008; 9(3):165-71. PubMed ID: 17853290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK; Adapa SR; Preeti K; Teja GR; Veeraragavan M; Krishnamurthy S
    J Ethnopharmacol; 2012 Aug; 143(1):91-9. PubMed ID: 22771318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
    Fuite J; Vernon SD; Broderick G
    Genomics; 2008 Dec; 92(6):393-9. PubMed ID: 18775774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The HPA axis in the pathogenesis of chronic fatigue syndrome].
    Ursini F; Succurro E; Grembiale A; Gagliardi DA; Arturi F
    Clin Ter; 2010; 161(5):461-4. PubMed ID: 20949245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the hypothalamic-pituitary-adrenal axis and autonomic nervous system during inflammation and altered programming of the neuroendocrine-immune axis during fetal and neonatal development: lessons learned from the model inflammagen, lipopolysaccharide.
    Karrow NA
    Brain Behav Immun; 2006 Mar; 20(2):144-58. PubMed ID: 16023324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.
    Wheatland R
    Med Hypotheses; 2005; 65(2):287-95. PubMed ID: 15885924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenocortical axis regulation.
    Jacobson L
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):271-92, vii. PubMed ID: 15850842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress, hypothalamic-pituitary-adrenal axis and eating disorders.
    Lo Sauro C; Ravaldi C; Cabras PL; Faravelli C; Ricca V
    Neuropsychobiology; 2008; 57(3):95-115. PubMed ID: 18552511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.